IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.296
0.00 (-0.10%)
At close: Feb 21, 2025, 4:00 PM
0.305
+0.009 (3.11%)
After-hours: Feb 21, 2025, 7:57 PM EST
IGC Pharma Employees
IGC Pharma had 67 employees as of March 31, 2024. The number of employees increased by 6 or 9.84% compared to the previous year.
Employees
67
Change (1Y)
6
Growth (1Y)
9.84%
Revenue / Employee
$18,448
Profits / Employee
-$131,478
Market Cap
23.59M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
IGC News
- 2 days ago - IGC Pharma Expands Holiby(TM) Product Line With 'Longevity' and 'Renew' - Targeting the Multi-Billion-Dollar Anti-Aging Market - Accesswire
- 4 days ago - IGC Pharma Reports Third Quarter Fiscal 2025 Results - Accesswire
- 11 days ago - IGC Pharma Expands Into $75 Billion Wellness Market with the Launch of Holiby(TM) - Accesswire
- 25 days ago - IGC Pharma Named Top 15 Finalist in NIA PREPARE Challenge for AI-Driven Early Detection of Alzheimer's Disease - Accesswire
- 5 weeks ago - IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets - Accesswire
- 6 weeks ago - IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer's Agitation "CALMA" and Expands Recruitment Strategy - Accesswire
- 2 months ago - IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025 - Accesswire
- 2 months ago - IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology - Accesswire